⌘K

Login Start Free

Home/Filings/4/0001601830-24-000173

4//SEC Filing

Dar Zavain 4

Accession 0001601830-24-000173

CIK 0001601830other

View on SEC.gov Company Profile

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 6:30 PM ET

Size

4.8 KB

Accession

0001601830-24-000173

Insider Transaction Report

Form 4

Period: 2024-10-01

RECURSION PHARMACEUTICALS, INC.RXRX

Director

Transactions

Award
Class A Common Stock
2024-10-01+2,229→ 106,225 total

Footnotes (1)

[F1]The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.

Documents

1 file

4
wk-form4_1728081013.xmlPrimary
FORM 4

Issuer

RECURSION PHARMACEUTICALS, INC.

CIK 0001601830

Entity typeother

Related Parties

1

filerCIK 0001852075

Filing Metadata

Form type: 4
Filed: Oct 3, 8:00 PM ET
Accepted: Oct 4, 6:30 PM ET
Size: 4.8 KB

View on SEC.gov